Ekaterina Викторовна Vyrupaeva

Dr. Ekaterina Викторовна Vyrupaeva

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
EVEkaterina Викторовна Vyrupaeva
Ekaterina Викторовна Vyrupaeva
NSNatalya Semenova
Natalya Semenova
LRL. V. Rychkova
L. V. Rychkova
APA. G. Petrova
A. G. Petrova
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
АСА. Ю. Самбялова
А. Ю. Самбялова
   The aim. To assess the general condition, laboratory parameters, quality of life of women of post-reproductive age after asymptomatic COVID-19 and 12 months after moderate COVID-19.   Material and methods. We examined 47 women (45–69 years old), divided into 3 groups: those who did not have COVID-19, not vaccinated (group 1 – control; n = 15); women 12 months after moderate COVID-19, accompanied by pneumonia (group 2; n = 19); women with IgG in their blood who deny any symptoms of COVID-19 (group 3; n = 13).   Results and discussion. An assessment of the general condition of women in post-reproductive age was carried out. In women 12 months after COVID-19 we found a lower level of total bilirubin compared to the group with asymptomatic COVID-19 (p = 0.004). An increase in thrombin time was determined in the groups of patients with symptomatic (p = 0.014) and asymptomatic (p = 0.025) COVID-19 course compared with the control group. Patients with asymptomatic COVID-19 course had a higher level of high-density lipoprotein cholesterol compared with the control group (p = 0.016) and the group 2 (p = 0.006). Compared with the control group, the group 2 had lower scores for general health (p = 0.006), vital activity (p = 0.013), general physical well-being (p = 0.039), physical functioning (p = 0.046); and the group 3 had higher scores in role functioning due to physical condition (p = 0.049). When comparing groups 2 and 3, lower scores in the group of women who recovered from the moderate COVID-19 were found in physical functioning (p = 0.002), pain intensity (p = 0.034), role functioning due to physical condition (p = 0.049), general health (p = 0.003), vital activity (p = 0.018), general physical well-being (p = 0.001).   Conclusion. 12 months after moderate COVID-19, there is a pronounced deterioration in physical and emotional health; and in asymptomatic patients, better protective functions of an organism can be assumed.

28 August 2024 in Pathophysiology
Verified
Journal Article
Open access
PDF file
NSNatalya Semenova
Natalya Semenova
EVEkaterina Викторовна Vyrupaeva
Ekaterina Викторовна Vyrupaeva
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
ONOlga Nikitina
Olga Nikitina
LKLiubov Kolesnikova
Liubov Kolesnikova
The assessment of endothelial dysfunction and free radical homeostasis parameters were performed in 92 women, aged 45 to 69 years, divided into the following groups: women without COVID-19 (unvaccinated, no antibodies, control); women with acute phase of COVID-19 infection (main group, COVID-19+); 12 months post COVID-19+; women with anti-SARS-CoV-2 IgG with no symptoms of COVID-19 in the last 12 months (asymptomatic COVID-19). Compared to the control, patients of the main group had lower glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities, decreased advanced glycation end products (AGEs) level, higher glutathione reductase (GR) activity, and higher glutathione S transferases pi (GSTpi), thiobarbituric acid reactants (TBARs), endothelin (END)-1, and END-2 concentrations (all p ≤ 0.05). The group with asymptomatic COVID-19 had lower 8-OHdG and oxidized glutathione (GSSG) levels, decreased total antioxidant status (TAS), and higher reduced glutathione (GSH) and GSH/GSSG levels (all p ≤ 0.05). In the group COVID-19+, as compared to the group without clinical symptoms, we detected lower GPx and SOD activities, decreased AGEs concentration, a higher TAS, and greater GR activity and GSTpi and TBARs concentrations (all p ≤ 0.05). The high content of lipid peroxidation products 12 months post COVID-19+, despite decrease in ENDs, indicates long-term changes in free radical homeostasis. These data indicate increased levels of lipid peroxidation production contribute, in part, to the development of free radical related pathologies including long-term post COVID syndrome.

3 May 2023 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
NSNatalya Semenova
Natalya Semenova
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
EVEkaterina Викторовна Vyrupaeva
Ekaterina Викторовна Vyrupaeva
LSL. F. Sholokhov
L. F. Sholokhov
LRL. V. Rychkova
L. V. Rychkova
LKL. I. Kolesnikova
L. I. Kolesnikova
The aim. To assess the thyroid status and its relationship with tumor necrosis factor alpha (TNF-alpha) in post-reproductive women in the acute phase of the COVID-19 of moderate course and 12 months after the disease.Materials and methods. 85 women aged 45 to 69 years were divided into groups: women without COVID-19, not vaccinated, with no antibodies to COVID-19 (IgG) – control group (n = 15); women in the acute phase of COVID-19 of a moderate course, accompanied by pneumonia – main group (n = 57); patients from the main group who agreed to be examined 12 months after having COVID-19 (n = 14); women with IgG in blood who deny any symptoms of COVID-19 in the last 12 months – asymptomatic COVID-19 (n = 13). Using hormone replacement therapy and the presence of thyroid disease in history were the exclusion criteria from the study.Results. 75.4 % of patients with COVID-19 had euthyroidism, 12.3 % had subclinical hyperthyroidism. An increase of free thyroxine (free T4) level in women with COVID-19 as compared to the control group (p = 0.004) and the group with asymptomatic COVID-19 (p = 0.054) was found. There was no statistically significant difference in the level of thyroid stimulating hormone between the groups. The level of C-reactive protein in women with COVID-19 was naturally higher as compared to the control group (p = 0.009) and the group of asymptomatic patients (p = 0.001). A lower TNF-alpha level was found in the group of patients without clinical signs of COVID-19 as compared to the control group (p = 0.007) and the group with COVID-19 (p = 0.00007). The analysis of correlation relationships revealed a positive correlation between of free T4 and TNF-alpha levels in women with COVID-19 (r = 0.38, p = 0.004).Conclusions. The moderate course of COVID-19 in the post-reproductive women is associated with an increase of free T4 level, which positively correlates with TNF-alpha level. Twelve months after COVID-19, thyroid status in women remains at the level of the acute phase of the disease.

8 October 2024 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
EVEkaterina Викторовна Vyrupaeva
Ekaterina Викторовна Vyrupaeva
NSNatalya Semenova
Natalya Semenova
LKLubov I. Kolesnikova
Lubov I. Kolesnikova
Pregnancy and menopause are critical periods in a woman’s life. Due to physiological changes in the neuroendocrine system regulation, susceptibility to respiratory viral infections increases in these periods, while affecting all organs and systems of the human body. The aim of this review was to analyze the literature data on the effect of acute respiratory viral infections on neuroendocrine regulation in women during pregnancy and menopause. We reviewed full-text publications in the public domain from the PubMed, eLibrary.ru, and Google Scholar databases with a coverage period of more than twenty years (2000–2023). Disruptions of the progesterone and estrogen production during infection with the influenza A (H1N1) and influenza B viruses have been shown in experimental studies. Hormonal status changes in pregnant women are detected during infection with the influenza A virus (H3N2) and depend on antiviral antibody titers and the presence of fetoplacental insufficiency. Pregnant women with COVID-19 may experience changes in the brain structure activities, as indicated by a high frequency of those in olfactory sensitivity and psychoemotional disorders. During menopause, infection with the SARS-CoV-2 virus leads to changes in the production of thyroxine, prolactin, estradiol, testosterone, cortisol, 17-hydroxyprogesterone, and dehydroepiandrosterone sulfate.

1 June 2024 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
NSNatalya Semenova
Natalya Semenova
EVEkaterina Викторовна Vyrupaeva
Ekaterina Викторовна Vyrupaeva
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
ENElizaveta Novikova
Elizaveta Novikova
LKL. I. Kolesnikova
L. I. Kolesnikova
The aim. The research was conducted to assess the total antioxidant and glutathione status, superoxide dismutase activity in menopausal women with moderate and asymptomatic COVID-19.Materials and methods. Ninety two women 45 to 69 years old were divided into groups: women without COVID-19, not vaccinated, with no antibodies to SARS-CoV-2 (IgG) – control; women with moderate COVID-19 – main group; women with anti-SARS-CoV-2 IgG in blood but who deny any symptoms of COVID-19 in the last 12 months – asymptomatic COVID-19.Results. A lower glutathione peroxidase (GPx), superoxide dismutase (SOD) activities and a higher glutathione reductase (GR) activity, glutathione S-transferase pi (GSTpi) concentrations were detected in the patients with moderate COVID-19 as compared to control. There were statistically lower oxidized glutathione (GSSG) levels, total antioxidant status (TAS) and higher reduced glutathione (GSH) levels, as well as GSH/GSSG ratio in the group with asymptomatic COVID-19 as compared to control. Significantly a lower GPx, SOD activities and a higher TAS, GR activity, GSTpi concentrations were detected in the patients with symptomatic COVID-19 as compared to group without clinical symptoms. ROC analysis shows the diagnostic significance of TAS (AUC = 0.714; p = 0.048), GSH (AUC = 0.714; p = 0.030), GSSG (AUC = 0.712; p = 0.031), GSH/GSSG (AUC = 0.837; p < 0.001) for group with asymptomatic COVID-19 compared with controls; TAS (AUC = 0.709; p = 0.020), SOD (AUC = 0.760; p < 0.001), GSH/GSSG (AUC = 0.658; p = 0.039), GPx (AUC = 0.774; p < 0.001), GSTpi (AUC = 0.864; p < 0.001) and GR (AUC = 0.871; p < 0.001) for group with moderate COVID-19 compared asympotmatic COVID-19.Conclusions. Antioxidant defense system activity in menopausal women depends on the COVID-19 course.

1 January 2021 in Transbaikalian Medical Bulletin
Verified
Journal Article
Closed access
VPV.A. Podkamenniy
V.A. Podkamenniy
ASA.A. Sharavin
A.A. Sharavin
YZY.V. Zheltovsky
Y.V. Zheltovsky
OKO.A. Kozina
O.A. Kozina
AVA.V. Vyrupaev
A.V. Vyrupaev
EVEkaterina Викторовна Vyrupaeva
Ekaterina Викторовна Vyrupaeva
Цель работы: выявить особенности при выполнении операции коронарного шунтирования (КШ) на «работающем сердце» у больных с терминальной стадией хронической болезни почек (ТСХБП), получающих лечение программным гемодиализом (ПГД). Материал и методы: в кардиохирургическом отделении №1 ГБУЗ Иркутской областной клинической больницы с 2010 года по 2020 год выполнено 4468 операций КШ на «работающем сердце». Из них 10 (0,2%) операций у больных ИБС с ТСХБП, получающих ПГД. Для решения поставленной задачи из оперированных больных сформированы две группы. Первая группа из больных с ТСХБП, получающих ПГД, и вторая группа (контрольная) из 20 больных с нормальной функцией почек. Сравнение больных в группах проведено по объему кровопотери по дренажам, времени ИВЛ, пребыванию ПИТиР и стационаре, динамике уровня креатинина, мочевины, калия и НВ, количества эритроцитов, тромбоцитов. Результаты: оперированные больные с ТСХБП достоверно не имели различий по сравнению с больными с нормальной функцией почек по количеству осложнений, времени ИВЛ (p =0,97), пребыванию ПИТиР (p=0,06) и стационаре, объему кровопотери по дренажам (p=0,3). После операции у больных с нормальной функцией почек (группа 2) отмечалось достоверное снижение количества эритроцитов и тромбоцитов, уровня HB без достоверного изменения показателей уровня мочевины, креатинина и калия в крови. Аналогичные изменения отмечались в общем и биохимическом анализе крови у больных с ТСХБП (первая группа). Заключение: ближайшие результаты операции КШ на «работающем сердце» у больных с ТСХБП, получающих ГД, не отличаются от результатов операций КШ у больных ИБС с нормальной функцией почек. Операция не нарушает сроки планового выполнения ГД. При выполнении операции КШ без искусственного кровообращения на «работающем сердце» допустим стандартный подход пред- и послеоперационного ведения больных с...